AEGISVOPAK - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 2.8
| Stock Code | AEGISVOPAK | Market Cap | 19,515 Cr. | Current Price | 176 ₹ | High / Low | 302 ₹ |
| Stock P/E | 110 | Book Value | 42.2 ₹ | Dividend Yield | 0.00 % | ROCE | 6.53 % |
| ROE | 7.70 % | Face Value | 10.0 ₹ | DMA 50 | 215 ₹ | DMA 200 | 238 ₹ |
| Chg in FII Hold | -0.04 % | Chg in DII Hold | -0.05 % | PAT Qtr | 51.1 Cr. | PAT Prev Qtr | 49.0 Cr. |
| RSI | 31.2 | MACD | -9.85 | Volume | 8,56,663 | Avg Vol 1Wk | 5,58,779 |
| Low price | 172 ₹ | High price | 302 ₹ | PEG Ratio | 0.30 | Debt to equity | 0.40 |
| 52w Index | 3.51 % | Qtr Profit Var | 50.3 % | EPS | 1.65 ₹ | Industry PE | 51.0 |
📊 AEGISVOPAK currently shows weak technicals for intraday trading. RSI at 31.2 indicates oversold conditions, but MACD remains negative (-9.85), suggesting bearish momentum. The stock trades well below both 50 DMA (215 ₹) and 200 DMA (238 ₹), reflecting sustained weakness. Intraday volume (8.56L) is higher than the 1-week average (5.58L), showing active participation, but price action remains under pressure.
💡 Optimal Buy Price: 172–176 ₹ (near support zone)
🎯 Profit-Taking Levels: 185–192 ₹ (short-term resistance)
🛑 Stop-Loss: 170 ₹ (recent low)
⏱️ If already holding: Exit near 185–190 ₹ if momentum stalls or volume weakens, as upside is capped by resistance and negative MACD.
Positive
- Quarterly PAT growth (51.1 Cr vs 49 Cr) shows steady improvement.
- PEG ratio of 0.30 suggests potential undervaluation relative to growth.
- EPS growth supported by recent profit variance of 50.3%.
Limitation
- Stock P/E of 110 is far above industry PE (51.0), indicating overvaluation.
- Weak ROCE (6.53%) and ROE (7.70%) highlight poor capital efficiency.
- Trading below both 50 DMA and 200 DMA confirms bearish trend.
- FII (-0.04%) and DII (-0.05%) holdings declined, showing reduced institutional confidence.
Company Negative News
- No major negative news reported, but valuation and weak returns remain concerns.
Company Positive News
- Quarterly profit variance up 50.3%, showing earnings momentum.
- EPS at 1.65 ₹ reflects profitability despite weak efficiency ratios.
Industry
- Industry PE at 51.0 is much lower than company PE (110), suggesting premium valuation.
- Sector growth remains steady, but high valuations may limit upside potential.
Conclusion
⚖️ AEGISVOPAK is fundamentally overvalued and technically weak for intraday trades today. Entry near 172–176 ₹ with a tight stop-loss at 170 ₹ is advisable only for aggressive traders. Upside potential is limited to 185–192 ₹, making it a risky intraday candidate rather than a strong buy.